We didn't start in MedTech. That's exactly why we saw what everyone inside it had stopped noticing.
Right now, somewhere in a medical device company, a quality team is copy-pasting complaint data into a spreadsheet. A regulatory affairs manager is manually assembling an MDR report that should have been submitted three days ago. The director of post-market surveillance is explaining to leadership again why the PSUR takes six weeks to generate. These are not bad teams.
These are exceptional people doing critical work with tools that were never built for it.
2.6 million MDRs were reported to the FDA last year. The teams responsible for filing them are not growing.
Post-market surveillance is not a back-office function. It is the mechanism by which the medical device industry keeps patients safe, regulators informed, and products on the market.
It is mandatory, consequential, and growing in complexity every year.
EU MDR enforcement is tightening.
Global regulatory requirements are multiplying.
Complaint volumes are rising.
And the industry is still managing it with generic quality management systems that were designed for document control, not for complaint intake, adverse event detection, regulatory reporting, or recall management.
The VP of Quality, who managed 50 complaints a month in 2019, is now managing 500.
The Regulatory Affairs director who filed MDRs for one market is now filing for twelve.
Headcount didn't triple. Budgets didn't triple. The workload did.
That is the problem Smarteeva was built to solve.
Not as a module inside a quality management system. Not as a bolt-on to a platform that was designed for something else.
As a purpose-built post-market surveillance platform from complaint intake to MDR submission, recall management to PSUR generation, engineered specifically for the regulatory realities that medical device companies face every day.
One platform. Same depth for a 10-person startup as a 10,000-person enterprise. No stripped-down tiers. No features locked behind contracts. The FDA doesn't send lighter regulations to smaller companies. Neither do we.
We started with a compliance product and believe that the tools should be as good as the people using them, regardless of the size of the company those people work for. That belief hasn't changed. The tools just got a lot better.
Plarent Ymeri
Smarteeva Founder and CEO
Our values
Built for the people who use it
Every feature is designed for the quality engineer at 7am triaging complaints and the regulatory specialist filing an MDR against a deadline. If it doesn't make their day easier, it doesn't ship.
Same platform. Every team size.
A three-person startup gets the same Smarteeva as a three-thousand-person enterprise. No stripped-down tiers. No features locked behind contracts. The FDA doesn't send lighter regulations to smaller companies. Neither do we.
Connected by design, not by integration
Complaints, investigations, adverse events, MDRs, and PMS reports share one data model. A change on a complaint updates the MDR automatically. No middleware. No reconciliation. One source of truth.
AI you can explain to an auditor
Every AI action is logged, what the model recommended, what data it used, and how the final decision was made. If an auditor asks "how did your AI decide this?", the answer is in the record. No black boxes.
Patient safety doesn't scale down
Post-market surveillance exists for one reason: keeping patients safe. That mission doesn't get easier because your company is smaller or your budget is tighter. We build for that reality, every product, every update, every decision.
1
2
3
4
5
See How AI Transforms Your Quality Workflow
Whether you're a 10-person startup or a global enterprise, this is the same platform. No tiers. No feature gates.
Trusted by leading enterprise companies around the world
Trusted by 450+ MedTech companies of every size